New Member Benefit!
ACCC’s newest resource for the multidisciplinary cancer care team, the Oncology Drug Database is a comprehensive, timely, easily understood, and authoritative source of information on coding, billing, and reimbursement for oncology drugs. ACCC’s Oncology Drug Database includes information for both provider administered (“Part B”) and prescribed (“Part D”) drugs commonly used in treating cancer patients in the ambulatory setting, including both therapeutics and supportive care products.
ACCC’s Oncology Drug Database is easy to use. Typing the drug name (generic or brand) into a search box will direct users to a drug-specific webpage with all of the information for that drug, including:
- Billing (HCPCS, NDC) and diagnosis (ICD-9 and ICD-10) codes
- Reimbursement amounts
- FDA-approved indications
- Drug manufacturer information, including contact information for the medical affairs department and reimbursement specialists (for drugs that remain under patent protection).
You can also search for drugs alphabetically by 1) clicking on the first letter of a drug’s name (brand or generic), and 2) then selecting either the"List by Brand Name" or the "List by Generic Name" tab at the top of the table.
Questions on how to use ACCC’s newest resource?